Stay updated on Dapagliflozin and Autonomic Function in T2D Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.

Latest updates to the Dapagliflozin and Autonomic Function in T2D Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant changes, including the addition of new collaborators, a revision number update, and modifications to the study's randomization and masking procedures. Notably, the detailed description of the study's purpose and design has been removed, which may impact the understanding of the study's objectives.SummaryDifference38%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Dapagliflozin and Autonomic Function in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.